Search results
Results from the WOW.Com Content Network
Insite is a supervised drug injection site in the Downtown Eastside (DTES) neighbourhood of Vancouver, British Columbia, Canada [1] The DTES had 4,700 chronic drug users in 2000 and has been considered to be the centre of an "injection drug epidemic". The site provides a supervised and health-focused location for injection drug use, primarily ...
The group's members have been actively involved in lobbying for support of Insite, North America's first safe injection site, located in the Downtown Eastside of Vancouver. [3] Its board of directors consists entirely of current and former drug addicts. [4] It was co-founded by Ann Livingston and Bud Osborn. [2]
For years, this Canadian city has hosted safe consumption sites for addicts. They've saved lives, but with some painful tradeoffs. Vancouver's safe drug-use sites are wrenching to see.
Supervised injection sites are also known as overdose prevention centers (OPCs), [6] supervised injection facilities, [7] safe consumption rooms, [8] safe injection sites, [1] safe injection rooms, [9] fix rooms, [10] fixing rooms, [11] safer injection facilities (SIF), drug consumption facilities (DCF), [2] drug consumption rooms (DCRs), [12] medically supervised injecting centres (MSICs) and ...
For premium support please call: 800-290-4726 more ways to reach us
For premium support please call: 800-290-4726 more ways to reach us
In September 2003, the PHS forced Vancouver Coastal Health to found Insite by constructing and opening the site illegally. Insite became North America's first supervised injection site. The Government was forced through the pressure of public opinion to issue a special exemption to the Controlled Drugs and Substances Act. [6] [failed verification]
Furthermore, in September 2003, Vancouver launched North America's first Supervised Injection Site, Insite, as part of its comprehensive Four Pillars Drug Strategy. This strategy, combining harm reduction measures with treatment, enforcement, and prevention efforts, aimed to address the endemic HIV and hepatitis C among injection drug users in ...